Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors

The mammalian CIP/KIP family of cyclin-dependent kinase (CDK) inhibitors (CKIs) comprises three proteins – p21Cip1/WAF1 , p27Kip1 , and p57Kip2 – that bind and inhibit cyclin–CDK complexes, which are key regulators of the cell cycle. CIP/KIP CKIs have additional independent functions in regulating t...

Full description

Saved in:
Bibliographic Details
Published in:Trends in cell biology 2012-01, Vol.22 (1), p.33-41
Main Authors: Starostina, Natalia G, Kipreos, Edward T
Format: Article
Language:English
Subjects:
Animals
Apoptosis
Cyclin-Dependent Kinase Inhibitor Proteins - metabolism
Humans
Pathology
Substrate Specificity
Transcription, Genetic
Ubiquitination
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The mammalian CIP/KIP family of cyclin-dependent kinase (CDK) inhibitors (CKIs) comprises three proteins – p21Cip1/WAF1 , p27Kip1 , and p57Kip2 – that bind and inhibit cyclin–CDK complexes, which are key regulators of the cell cycle. CIP/KIP CKIs have additional independent functions in regulating transcription, apoptosis and actin cytoskeletal dynamics. These divergent functions are performed in distinct cellular compartments and contribute to the seemingly contradictory observation that the CKIs can both suppress and promote cancer. Multiple ubiquitin ligases (E3s) direct the proteasome-mediated degradation of p21, p27 and p57. This review analyzes recent data highlighting our current understanding of how distinct E3 pathways regulate subpopulations of the CKIs to control their diverse functions.
ISSN:0962-8924
1879-3088
DOI:10.1016/j.tcb.2011.10.004